Form 4 for CELU Celularity Inc
Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-19 · accession 0001493152-25-028780 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-22 | 2025-12-19 | CELU | Ling Geoffrey M.D. | Dir | A - Grant | $0.00 | +67.4K | 111.8K | +152% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-19 | A | A | 67,416 | $0.00 | 111,795 | D | — | — | (F1) These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025. |